# data[].attributes.body
Emergent treatment for severe hyperkalemia

# data[].attributes.body
Increases fecal potassium excretion by binding potassium in the lumen of the GI tract. This reduces the concentration of free potassium in the lumen of the intestinal tract. This, as a result, decreases potassium levels.

# data[].attributes.body
-hypokalemia, hypernatremia, hypocalcemia, hypomagnesemia, sodium retention
-diarrhea, anorexia, constipation, fecal impaction, nausea, vomiting

# data[].attributes.body
Before administering sodium polystyrene sulfonate (Kayexalate) to a patient with hyperkalemia, the nurse should assess the

a. blood urea nitrogen (BUN) and creatinine.
b. blood glucose level.
c. patient's bowel sounds.
d. level of consciousness (LOC).

# data[].attributes.body
Monitor the ECG until the potassium is normal. Monitor their bowel function because it can cause constipation or fecal impaction.

# data[].attributes.body
https://online-lexi-com.proxygw.wrlc.org/lco/action/doc/retrieve/docid/patch_f/7686?cesid=1VCZ0Zsi1KU&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dkayexalate%26t%3Dname%26acs%3Dtrue%26acq%3Dkayexa#phk

# data[].attributes.attachment_link.readable_text
If your browser does not continue automatically, click

# data[].attributes.body
Onset of action: hours to days
Excretion: completely through feces